Amitav Acharya

Professor, The Boeing Company Chair in International Relations (2016-2017) (2017-2018)

Distinguished Professor and the UNESCO Chair in Transnational Challenges and Governance, School of International Service, American University, Washington, DC

Professor Acharya was the inaugural Boeing Company Chair in International Relations at the Schwarzman Scholars Program in 2016-18. He has held fellowships at Harvard’s Asia Center and Kennedy School of Government and was elected to the Christensen Fellowship at Oxford in 2013. His books include The End of American World Order (Polity, 2014, 2018); Constructing Global Order (Cambridge, 2018); and The Making of Global International Relations: Origins and Evolution of IR at Its Centenary (co-author with Barry Buzan, Cambridge, 2019). His articles and op-eds have appeared in International Organization, International Security, International Studies Quarterly, International Affairs, World Politics, Financial Times, Foreign Affairs, Washington Post, International Herald Tribune/ Global New York Times, Times of India, Australian Financial Review, and YaleGlobal Online. He has been interviewed by BBC, CNN, CNBC, and National Public Radio (NPR) and other world media. He is the first non-Western scholar to be elected as President of the International Studies Association (ISA), the largest and most influential global network in international studies. ISA has honored him with two Distinguished Scholar Awards: in 2015 for his “outstanding contribution to scholarship on non-Western IR theory and inclusion in IR” and another in 2018 for “exceptional… influence, intellectual works and mentorship” in the field of international organization.

Cookie Policy

This website uses cookies, including third-party cookies, in order to obtain information about your visit to the website and make this website better. Please click on the link "Learn More" if you would like more information about the cookies used on this website and how to change your cookie settings. Otherwise, we will assume you’re OK to continue.

Learn more